MediPharm Labs Corp. (TSE:LABS – Get Free Report) traded up 7.7% during trading on Thursday . The company traded as high as C$0.08 and last traded at C$0.07. 713,415 shares changed hands during trading, an increase of 107% from the average session volume of 344,238 shares. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10. The company has a market cap of C$29.05 million, a PE ratio of -2.41 and a beta of 0.88. The business has a fifty day simple moving average of C$0.07 and a two-hundred day simple moving average of C$0.07.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Further Reading
- Five stocks we like better than MediPharm Labs
- What Does a Stock Split Mean?
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Using the MarketBeat Dividend Yield Calculator
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
- EV Stocks and How to Profit from Them
- MarketBeat Week in Review – 02/10 – 02/14
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
